Condition
Low Rectal Cancer
Total Trials
5
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
P 2 (2)
Trial Status
Unknown2
Enrolling By Invitation1
Not Yet Recruiting1
Recruiting1
Clinical Trials (5)
Showing 5 of 5 trials
NCT07463261Not ApplicableNot Yet Recruiting
REsults of LOw Anterior Resections With or Without Preventive Stoma in Nonemergency Department
NCT07346534Not ApplicableEnrolling By InvitationPrimary
Reinforced Versus Conventional Anastomosis in Laparoscopic Low Rectal Cancer Resection: A Comparative Study
NCT05972655Phase 2RecruitingPrimary
Nodes-sparing Short-course Radiation Combined With CAPOX and Tislelizumab for MSS Middle and Low Rectal Cancer
NCT02488577Not ApplicableUnknownPrimary
Outcomes of TAMIS-Total Mesorectal Excision Versus Transanal Loco-regional Excision for T2 Low Rectal Cancer
NCT02468362Phase 2UnknownPrimary
Long Term Outcomes After Laparoscopic Intersphincteric Resection With Total Mesorectal Excision for Low Rectal Cancer.
Showing all 5 trials